The page lists 23 projects related to the topic "aggressiveness".
|COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma
|Biomarker Guided Prostate Cancer Management
|Discovery of breast cancer aggressiveness markers using topo-proteomics mapping
|Validation of blood-brain-barrier permeability as a glioma biomarker by means of the radiotracer 99mTc-tetrofosmin and single-photon emission computer tomography
|Theranostic Injectable Hydrogel for Glioblastoma
|Feasibility study of a NOvel METAbolic liquid biopsy for cancer therapy monitoring
|Functional and Molecular Characterisation of Breast Cancer Stem Cells
|Surviving metabolism: acid handling and signalling
|Study of the role of m6A RNA methylation in the nervous system of Drosophila melanogaster: an in-vivo model to dissect the impact of epitranscriptome reprogramming in physiology and cancer
|Stromal stress networks underlying phenotypic plasticity and tumor fitness
|Direct detection of cancer-causing mutations in tumour specimens
|Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate.
|Mechanism and vulnerability of BAP1 loss in tumor metastasis
|RustWatch: A European early-warning system for wheat rust diseases
|Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia
|Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation
|Single-cell genomics to comprehensively understand healthy B-cell maturation and transformation to chronic lymphocytic leukemia
|Endosome positioning in tumour-stroma interactions
|Improved glioblastoma treatment through targeted, local drug delivery
|Functional Keratin Kerasol
|LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme
|Implementation of contrast-ultrasound dispersion imaging for better prostate cancer care
|Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine.